A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Glaukos Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 9,829 shares of GKOS stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,829
Holding current value
$1.48 Million
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$113.62 - $135.39 $1.12 Million - $1.33 Million
9,829 New
9,829 $1.28 Million
Q4 2023

Feb 14, 2024

SELL
$59.53 - $85.11 $227,642 - $325,460
-3,824 Reduced 25.12%
11,400 $906,000
Q3 2023

Nov 15, 2023

SELL
$69.23 - $79.09 $4.35 Million - $4.97 Million
-62,782 Reduced 80.48%
15,224 $1.15 Million
Q2 2023

Aug 14, 2023

SELL
$45.44 - $71.21 $1.89 Million - $2.97 Million
-41,656 Reduced 34.81%
78,006 $5.55 Million
Q1 2023

May 15, 2023

BUY
$43.88 - $52.48 $2.14 Million - $2.56 Million
48,749 Added 68.74%
119,662 $6 Million
Q4 2022

Feb 14, 2023

BUY
$40.82 - $57.75 $1.22 Million - $1.72 Million
29,781 Added 72.4%
70,913 $3.1 Million
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $1.21 Million - $1.51 Million
25,816 Added 168.56%
41,132 $2.19 Million
Q2 2022

Aug 15, 2022

BUY
$34.86 - $63.77 $533,915 - $976,701
15,316 New
15,316 $696,000
Q4 2021

Feb 14, 2022

SELL
$40.27 - $56.99 $1.81 Million - $2.57 Million
-45,032 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$47.43 - $84.23 $2.14 Million - $3.79 Million
45,032 New
45,032 $2.17 Million
Q1 2021

May 17, 2021

SELL
$70.43 - $97.42 $1.18 Million - $1.64 Million
-16,807 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$48.9 - $75.26 $821,862 - $1.26 Million
16,807 New
16,807 $1.27 Million
Q3 2020

Nov 16, 2020

SELL
$37.23 - $50.97 $594,265 - $813,583
-15,962 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$28.78 - $46.83 $459,386 - $747,500
15,962 New
15,962 $613,000
Q1 2020

May 15, 2020

SELL
$25.53 - $70.14 $951,298 - $2.61 Million
-37,262 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$54.18 - $65.64 $2.02 Million - $2.45 Million
37,262 New
37,262 $2.03 Million
Q3 2019

Nov 14, 2019

SELL
$58.58 - $83.91 $1.72 Million - $2.46 Million
-29,326 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$63.59 - $78.71 $1.47 Million - $1.82 Million
23,117 Added 372.31%
29,326 $2.21 Million
Q1 2019

May 15, 2019

BUY
$50.75 - $80.54 $315,106 - $500,072
6,209 New
6,209 $487,000
Q1 2018

May 15, 2018

SELL
$26.05 - $34.5 $269,695 - $357,178
-10,353 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$24.5 - $36.01 $253,648 - $372,811
10,353
10,353 $266,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.